Market Scenario for Global Anti-Hypertensive Drugs Market:
Anti-hypertensive drugs are used to treat hypertension (high blood pressure). Hypertension is a state of chronic elevated arterial blood pressure at or greater than 140/90 mm Hg for adults.
The global anti-hypertensive drugs market was valued at $32.2 billion in 2022, and is expected to reach $ 38.9 billion by 2030. Thus the antihypertensive medication market is expected to perform sluggish growth at a CAGR of 2.73% from 2022 to 2030.
The constraints however are overwhelming and include patent expiries such as Actelion's Tracleer (2022), and United Therapeutic's Remodulin (2022). Other blockbuster’s such as Novartis's Diovan and Exforge, Sanofi Aventis's Avapro (2012) etc are also off-patent.
Key Players for Global Anti-Hypertensive Drugs Market:
Novartis AG, Daiichi Sankyo Company Limited, Acetelion Ltd, Boehringer Ingelheim, Sanofi S.A., Astra Zeneca plc, Ranbaxy Laboratories Limited, Inc., Takeda Pharmaceuticals Company Limited, Pfizer Inc.
Segments Global Anti-Hypertensive Drugs Market:
Global anti-hypertensive drugs market has been segmented on the basis of pharmacological class, hypertension type, disease source and Region.
Study Objectives Global Anti-Hypertensive Drugs Market:
To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and sub-segments of the global anti-hypertensive drugs market
To provide insights about factors affecting the market growth
To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
To provide country level analysis of the market with respect to the current market size and future prospective.
To provide country level analysis of the market for segments and sub-segments.
To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.
Regional Analysis Global Anti-Hypertensive Drugs Market:
Globally North America is the largest market for global anti-hypertensive drugs. Europe is the second-largest market for global anti-hypertensive drugs.
The near future market for anti-hypertensive drugs will be dominated by the developed regions with developing regions providing a supporting role only.
However the developing regions market particularly Asia Pacific will be the fastest growing and is likely to be the key to the future.
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013,
United States of America